Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
iSpecimen ( (ISPC) ) has issued an update.
On June 4, 2025, iSpecimen Inc. received a notification from Nasdaq indicating non-compliance with the minimum stockholders’ equity requirement of $2.5 million for continued listing on the Nasdaq Capital Market, as their equity was reported at $1,668,513. The company has 45 days to submit a compliance plan, and if accepted, may receive an extension of up to 180 days to meet the listing criteria, although there is no guarantee of acceptance or compliance.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
The overall stock score of 40.4 reflects significant financial challenges, poor valuation metrics, and bearish technical trends. The financial performance is a major concern with declining revenues and persistent losses. The technical analysis suggests a bearish trend, and the negative P/E ratio indicates a lack of profitability. Improvements are necessary for a positive outlook.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 77,636
Technical Sentiment Signal: Sell
Current Market Cap: $3.18M
For a thorough assessment of ISPC stock, go to TipRanks’ Stock Analysis page.